Letter from the Editor


Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at

SKU: 1877. Category: .

Product Description

    The consensus is pretty clear: 2009 is best left behind. People began writing off this year back in June and started setting their sights on first-quarter 2010. Fiscal projections aside, this Gregorian leapfrog of the calendar was more of a mindset throughout the industry: Let’s just get to the end of the year. Barraged by bad news daily — plummeting 401(k)s; unprecedented layoffs throughout every business sector, including our industry’s top performers; and a looming and overarching healthcare reform bill with the potential to constrict business operations — it’s no wonder that we are less than eager to wax reminiscent about the year gone by.
    As our experts predicted last year, cutbacks, layoffs, buyouts, patent expirations, and mergers and acquisitions were, and continue to be, some of the challenges that are likely to have major ramifications for the way in which the life-sciences industry innovates, develops, markets, and distributes its medicines…